These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 23427326)

  • 1. A novel α-synuclein missense mutation in Parkinson disease.
    Proukakis C; Dudzik CG; Brier T; MacKay DS; Cooper JM; Millhauser GL; Houlden H; Schapira AH
    Neurology; 2013 Mar; 80(11):1062-4. PubMed ID: 23427326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease.
    Hoffman-Zacharska D; Koziorowski D; Ross OA; Milewski M; Poznanski JA; Jurek M; Wszolek ZK; Soto-Ortolaza A; Awek JAS; Janik P; Jamrozik Z; Potulska-Chromik A; Jasinska-Myga B; Opala G; Krygowska-Wajs A; Czyzewski K; Dickson DW; Bal J; Friedman A
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1057-1060. PubMed ID: 23916651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.
    Kiely AP; Ling H; Asi YT; Kara E; Proukakis C; Schapira AH; Morris HR; Roberts HC; Lubbe S; Limousin P; Lewis PA; Lees AJ; Quinn N; Hardy J; Love S; Revesz T; Houlden H; Holton JL
    Mol Neurodegener; 2015 Aug; 10():41. PubMed ID: 26306801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity.
    Khalaf O; Fauvet B; Oueslati A; Dikiy I; Mahul-Mellier AL; Ruggeri FS; Mbefo MK; Vercruysse F; Dietler G; Lee SJ; Eliezer D; Lashuel HA
    J Biol Chem; 2014 Aug; 289(32):21856-76. PubMed ID: 24936070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease.
    Blauwendraat C; Kia DA; Pihlstrøm L; Gan-Or Z; Lesage S; Gibbs JR; Ding J; Alcalay RN; Hassin-Baer S; Pittman AM; Brooks J; Edsall C; Chung SJ; Goldwurm S; Toft M; Schulte C; ; Hernandez D; Singleton AB; Nalls MA; Brice A; Scholz SW; Wood NW
    Neurobiol Aging; 2018 Apr; 64():159.e5-159.e8. PubMed ID: 29398121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.
    Appel-Cresswell S; Vilarino-Guell C; Encarnacion M; Sherman H; Yu I; Shah B; Weir D; Thompson C; Szu-Tu C; Trinh J; Aasly JO; Rajput A; Rajput AH; Jon Stoessl A; Farrer MJ
    Mov Disord; 2013 Jun; 28(6):811-3. PubMed ID: 23457019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous alpha-synuclein p.A53V in familial Parkinson's disease.
    Yoshino H; Hirano M; Stoessl AJ; Imamichi Y; Ikeda A; Li Y; Funayama M; Yamada I; Nakamura Y; Sossi V; Farrer MJ; Nishioka K; Hattori N
    Neurobiol Aging; 2017 Sep; 57():248.e7-248.e12. PubMed ID: 28666710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The many faces of alpha-synuclein mutations.
    Kasten M; Klein C
    Mov Disord; 2013 Jun; 28(6):697-701. PubMed ID: 23674458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.
    Ghosh D; Mondal M; Mohite GM; Singh PK; Ranjan P; Anoop A; Ghosh S; Jha NN; Kumar A; Maji SK
    Biochemistry; 2013 Oct; 52(40):6925-7. PubMed ID: 24047453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson's Disease.
    Zhu XX; Zhong YZ; Ge YW; Lu KH; Lu SS
    Sci Rep; 2018 Aug; 8(1):12420. PubMed ID: 30127453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity.
    Sanjeev A; Mattaparthi VSK
    J Biomol Struct Dyn; 2018 Jul; 36(9):2224-2236. PubMed ID: 28650719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of SNCA coding mutation in Chinese Han patients with Parkinson disease.
    Deng S; Deng X; Yuan L; Song Z; Yang Z; Xiong W; Deng H
    Acta Neurol Belg; 2015 Sep; 115(3):267-71. PubMed ID: 25092551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.
    Covy JP; Giasson BI
    Neurotoxicology; 2011 Oct; 32(5):622-9. PubMed ID: 21238487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.
    Lesage S; Anheim M; Letournel F; Bousset L; Honoré A; Rozas N; Pieri L; Madiona K; Dürr A; Melki R; Verny C; Brice A;
    Ann Neurol; 2013 Apr; 73(4):459-71. PubMed ID: 23526723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper Binding and Subsequent Aggregation of α-Synuclein Are Modulated by N-Terminal Acetylation and Ablated by the H50Q Missense Mutation.
    Mason RJ; Paskins AR; Dalton CF; Smith DP
    Biochemistry; 2016 Aug; 55(34):4737-41. PubMed ID: 27517125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.
    Proukakis C; Houlden H; Schapira AH
    Mov Disord; 2013 Jun; 28(6):705-12. PubMed ID: 23674490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology.
    Wilson GR; Sim JC; McLean C; Giannandrea M; Galea CA; Riseley JR; Stephenson SE; Fitzpatrick E; Haas SA; Pope K; Hogan KJ; Gregg RG; Bromhead CJ; Wargowski DS; Lawrence CH; James PA; Churchyard A; Gao Y; Phelan DG; Gillies G; Salce N; Stanford L; Marsh AP; Mignogna ML; Hayflick SJ; Leventer RJ; Delatycki MB; Mellick GD; Kalscheuer VM; D'Adamo P; Bahlo M; Amor DJ; Lockhart PJ
    Am J Hum Genet; 2014 Dec; 95(6):729-35. PubMed ID: 25434005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.
    Xiong WX; Sun YM; Guan RY; Luo SS; Chen C; An Y; Wang J; Wu JJ
    J Neurol; 2016 Oct; 263(10):1984-92. PubMed ID: 27393118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease.
    Voutsinas GE; Stavrou EF; Karousos G; Dasoula A; Papachatzopoulou A; Syrrou M; Verkerk AJ; van der Spek P; Patrinos GP; Stöger R; Athanassiadou A
    Hum Mutat; 2010 Jun; 31(6):685-91. PubMed ID: 20340137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.